Underwood Capital Limited has released a press release.
Update on the PTL Disposal
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
- Prospectus
- Postponement of General Meeting
- OCS supply agreements for MMJ investee companies
- MediPharm signs customer contracts ahead of TSX-V listing
- PTL completes Phase 2 clinical trial
Later from Underwood Capital
- Results of Meeting
- MediPharm Labs enters contract with Emerald
- Update on PTL Disposal and MMJ Suspension
- Portfolio management update
- Appendix 4C - quarterly
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital